Kringle Pharma Inc 4884.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 05/27/22 JST
571.00quote price arrow up+8.00 (+1.42%)
Volume
12,300
52 week range
542.00 - 1,329.00
Loading...
  • Open570.00
  • Day High575.00
  • Day Low565.00
  • Prev Close563.00
  • 52 Week High1,329.00
  • 52 Week High Date06/25/21
  • 52 Week Low542.00
  • 52 Week Low Date05/10/22

Key Stats

  • Market Cap22.3M
  • Shares Out4.99M
  • 10 Day Average Volume21,081.82
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-16.03

KEY STATS

  • Open570.00
  • Day High575.00
  • Day Low565.00
  • Prev Close563.00
  • 52 Week High1,329.00
  • 52 Week High Date06/25/21
  • 52 Week Low542.00
  • 52 Week Low Date05/10/22
  • Market Cap22.3M
  • Shares Out4.99M
  • 10 Day Average Volume21,081.82
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-16.03

RATIOS/PROFITABILITY

  • EPS (TTM)-256.90
  • P/E (TTM)-2.22
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kringle Pharma Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Kringle Pharma Inc is a Japan-based company mainly engaged in the development of pharmaceuticals. The Company is involved in the research and development of therapeutic agents for intractable diseases using hepatocyte growth factor (HGF) protein. HGF has versatile bioactivity that is responsible for tissue or organ regeneration and protection such as cell proliferation promotion, cell motility promotion, anti-apoptosis, morphogenesis induction, and angiogenesis. HGF has a...
Kiichi Adachi Ph.D.
President, Chief Executive Officer, Representative Director
Address
207
Saito Bio Incubator, 7-7-15, Saitoasagi
Ibaraki-shi, OSK
567-0085
Japan